Skip to content

RESPONSE BIOMEDICAL CORP

CIK 0000806888

← back to feed
Revenue (TTM)
8.64M
+40.0% YoY Q3 Nov 2016
Net Income (TTM)
−1.67M
+92.8% YoY Q3 Nov 2016
EPS Diluted (TTM)
−0.05
Q3 Nov 2016
Gross Margin
50.0%
Q3 Nov 2016
Operating Margin
—
Q3 Nov 2016
Net Margin
-19.4%
Q3 Nov 2016
Free Cash Flow (TTM)
−4.25M
Q3 Nov 2016
Cash
1.35M
Q3 Nov 2016
Total Debt
684K
Q3 Nov 2016
Shares Outstanding
10.92M sh
Q3 Nov 2016

Revenue & Net Income

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings